4519:TYO
Chugai Pharmaceutical Co Ltd
Â¥6,120.00
arrow_upward
+0.51%(+31.00) 1D
Oct 6, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
Â¥6,118
High
Â¥6,148
Low
Â¥6,039
Mkt. cap
10.28T
Avg. vol.
2.89M
Volume
2.43M
Dividend
2.25%
Quarterly dividend
Â¥35
Ex-dividend date
Jun 29, 2026
P/E ratio
21.37
52-wk high
Â¥10,700
52-wk low
Â¥5,974
EPS
Â¥286
Shares outstanding
547.19M
No. of employees
5K
Open
Â¥6,118
High
Â¥6,148
Low
Â¥6,039
Mkt. cap
10.28T
Avg. vol.
2.89M
Volume
2.43M
Dividend
2.25%
Quarterly dividend
Â¥35
Ex-dividend date
Jun 29, 2026
P/E ratio
21.37
52-wk high
Â¥10,700
52-wk low
Â¥5,974
EPS
Â¥286
Shares outstanding
547.19M
No. of employees
5K
News stories
From web sources and news partners
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp